serine has been researched along with ristocetin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Houghten, RA; Ruggeri, ZM; Vicente, V | 1 |
Perkins, HR | 1 |
Petit, JF; Söll, D; Strominger, JL | 1 |
Ikeda, Y; Matsubara, Y; Murata, M; Sugita, K | 1 |
1 review(s) available for serine and ristocetin
Article | Year |
---|---|
Composition of bacterial cell walls in relation to antibiotic action.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacitracin; Bacteria; Carbamates; Cell Wall; Cephalosporins; Cycloserine; Escherichia coli; Glucosamine; Lipid Metabolism; Lysostaphin; Nucleotides; Penicillins; Peptides; Ristocetin; Serine; Staphylococcus; Vancomycin | 1969 |
3 other study(ies) available for serine and ristocetin
Article | Year |
---|---|
Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
Topics: Amino Acid Sequence; Asialoglycoproteins; Binding Sites; Blood Platelets; Crotalid Venoms; Disulfides; Humans; Molecular Sequence Data; Peptide Fragments; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Ristocetin; Serine; Tyrosine; von Willebrand Factor | 1990 |
Biosynthesis of the peptidoglycan of bacterial cell walls. VII. Incorporation of serine and glycine into interpeptide bridges in Staphylococcus epidermidis.
Topics: Alcohols; Bacitracin; Carbon Isotopes; Cell Wall; Chloramphenicol; Chlortetracycline; Chromatography, Ion Exchange; Cycloserine; Erythromycin; Glycoproteins; Lincomycin; Novobiocin; Penicillins; Peptide Biosynthesis; Polysaccharides, Bacterial; Puromycin; Ristocetin; Serine; Staphylococcus; Streptomycin; Surface-Active Agents; Tritium; Vancomycin | 1968 |
Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
Topics: Bleeding Time; Blood Platelets; Blood Proteins; Cell Line; Child, Preschool; Dose-Response Relationship, Drug; Family Health; Genetic Vectors; Genotype; Glycine; Glycoproteins; Hemorrhage; Heterozygote; Humans; Immunoglobulins; Japan; Male; Mutation; Phenotype; Platelet Aggregation; Point Mutation; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins; Ristocetin; Serine; Thrombocytopenia; von Willebrand Diseases; von Willebrand Factor | 2003 |